DeepMed Research

University of Virginia

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1819-01-01

Employees: 10K

Market Cap: -

Website: http://www.virginia.edu

Clinical Trials

Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics

Phase 2

Active, not recruiting

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: Anoro Ellipta
Drug: Arnuity Ellipta

First Posted Date: 2016-12-23

Last Posted Date: 2024-11-18

Lead Sponsor: University of Virginia

Target Recruit Count: 95

Registration Number: NCT03002389

Locations: 🇺🇸
Roselove NUNOO-ASARE, Keswick, Virginia, United States

Assessing Deformable Image Registration in the Lung Using Hyperpolarized-gas MRI

Phase 1

Conditions: Healthy Volunteers

Interventions: Drug: Hyperpolarized He3

First Posted Date: 2016-12-16

Last Posted Date: 2020-11-04

Lead Sponsor: University of Virginia

Target Recruit Count: 24

Registration Number: NCT02995590

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Midodrine in the Recovery Phase of Septic Shock

Phase 3

Withdrawn

Conditions: Septic Shock

Interventions: Other: Standard of Care
Drug: midodrine

First Posted Date: 2016-12-13

Last Posted Date: 2024-01-11

Lead Sponsor: University of Virginia

Registration Number: NCT02990546

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

Not Applicable

Completed

Conditions: Type1 Diabetes Mellitus

Interventions: Other: Sensor Augmented Therapy
Device: Artificial Pancreas

First Posted Date: 2016-12-07

Last Posted Date: 2022-12-05

Lead Sponsor: University of Virginia

Target Recruit Count: 127

Registration Number: NCT02985866

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
William Sansum Diabetes Center, Santa Barbara, California, United States

and more 4 locations

A Trial of Alirocumab and Plaque Regression in Peripheral Arterial Disease

Phase 4

Completed

Conditions: Peripheral Arterial Disease

Interventions: Drug: Matching placebo
Drug: Alirocumab

First Posted Date: 2016-11-08

Last Posted Date: 2023-05-10

Lead Sponsor: University of Virginia

Target Recruit Count: 40

Registration Number: NCT02959047

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States

Evaluating and Improving Functional Driving Vision of Patients With Astigmatism: Phase 3

Not Applicable

Completed

Conditions: Astigmatism

Interventions: Device: Placebo Lenses
Device: Spherical Lenses
Device: Toric Lenses

First Posted Date: 2016-11-01

Last Posted Date: 2021-10-06

Lead Sponsor: University of Virginia

Target Recruit Count: 51

Registration Number: NCT02950545

Locations: 🇺🇸
University of Virginia Driving Safety Laboratory, Charlottesville, Virginia, United States

IRB-HSR # 14073 Investigation of Pelvic Girdle Dysfunction in the Low Back Pain Population

Phase 2

Completed

Conditions: Back Pain

Interventions: Other: SIJ pain diagnostic tests

First Posted Date: 2016-10-31

Last Posted Date: 2016-10-31

Lead Sponsor: University of Virginia

Target Recruit Count: 55

Registration Number: NCT02950129

Locations: 🇺🇸
UVA Pain Management Center, Charlottesville, Virginia, United States

Clinical Response to Rhinovirus Challenge

Phase 2

Completed

Conditions: Allergic Rhinitis
Asthma

Interventions: Biological: Rhinovirus (GMP RV16 HRV-16)

First Posted Date: 2016-09-22

Last Posted Date: 2024-01-09

Lead Sponsor: University of Virginia

Target Recruit Count: 38

Registration Number: NCT02910401

Locations: 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States

Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Rate Reduction
Drug: Pharmacological
Behavioral: Brief Advice
Behavioral: Motivational Interviewing
Behavioral: MI+RR

First Posted Date: 2016-09-19

Last Posted Date: 2024-03-01

Lead Sponsor: University of Virginia

Target Recruit Count: 903

Registration Number: NCT02905656

Locations: 🇺🇸
University of Tennessee Health Science Center, Memphis, Tennessee, United States

Comparing the Effectiveness of Lung Expansion Therapy in Adult Human Subjects

Not Applicable

Completed

Conditions: Atelectasis

Interventions: Device: Incentive Spirometry
Device: EzPAP® Positive Airway Pressure

First Posted Date: 2016-09-08

Last Posted Date: 2018-11-19

Lead Sponsor: University of Virginia

Target Recruit Count: 112

Registration Number: NCT02892773

Locations: 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy